Search
Bill number does not exist. Enter a vaild keyword.

Legislation

Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Prescription Drug Monitoring Program - Program Evaluation
Sponsored by
Chair, Finance Committee
Status
In the Senate - Hearing 2/14 at 1:00 p.m.
Analysis
Fiscal and Policy Note
Synopsis
Requiring the Prescription Drug Monitoring Program to provide prescription monitoring data to authorized users, rather than the authorized administrator, of another state's prescription drug monitoring program; repealing the termination date of the Program; repealing the requirement that the Department of Legislative Services conduct a certain evaluation of the Program under the Maryland Program Evaluation Act; etc.
Committees
Original:
Finance  
Details
Cross-filed with: HB0466
Bill File Type: Regular
Effective Date(s): October 1, 2019
History
Legislation History
Chamber
Senate
Calendar Date
1/30/2019
Legislative Date
1/30/2019
Action
First Reading Finance
Proceedings
Chamber
Calendar Date
Legislative Date
Action
Text - First - Prescription Drug Monitoring Program - Program Evaluation
Proceedings
Chamber
Senate
Calendar Date
2/01/2019
Legislative Date
2/01/2019
Action
Hearing 2/14 at 1:00 p.m.
Proceedings
Chamber Calendar Date Legislative Date Action Proceedings
Senate 1/30/2019 1/30/2019 First Reading Finance
Text - First - Prescription Drug Monitoring Program - Program Evaluation
Senate 2/01/2019 2/01/2019 Hearing 2/14 at 1:00 p.m.
File Code
Subjects
Statutes
(   21-2A-06, 21-2A-10 )
Last Updated: 2/3/2020 2:33 PM